Bill
HB 126
The bill standardizes how controlled-drug prescriptions are written, dispensed, and monitored to improve safety and reduce misuse through enhanced prescribing rules, PDMP use, and
Title: Relative to prescriptions for certain controlled drugs
Jurisdiction: New Hampshire
Purpose and intent
- The bill addresses how prescriptions for certain controlled drugs are to be written, dispensed, or managed within the state’s health care and regulatory framework.
- It aims to modify requirements around prescribing practices to ensure safety, oversight, and appropriate use of controlled substances.
Key provisions and changes (highlights)
-Prescription standards
- The bill sets specific criteria for prescribing certain controlled drugs, including what information must appear on the prescription (e.g., dosage, quantity, duration, prescribing clinician identifiers).
- It may establish rules regarding alignment with state-controlled substances schedules and with federal DEA regulations.
-Prescriber requirements and oversight
- Requirements for prescribers (medical doctors, nurse practitioners, physician assistants, etc.) related to credentialing, verification, and potential notification to a regulatory or monitoring authority when issuing prescriptions for controlled substances.
- Potential creation or empowerment of a monitoring program or use of an existing prescription drug monitoring program (PDMP) to track prescriptions and detect patterns of misuse or diversion.
-Pharmacy workflow and dispensing
- Provisions governing how pharmacies process prescriptions for these drugs, including verification steps, recordkeeping, and potential limitations on quantities or refill practices.
- May specify timelines for submitting prescription data to the PDMP and rules on patient identity verification.
-Patient safety and public health measures
- Provisions intended to reduce misuse, overprescribing, or unsafe combinations (e.g., concurrent prescriptions, dangerous drug interactions).
- Could include education requirements for patients receiving controlled substances or prescriber-patient communication standards.
-Enforcement and penalties
- The bill likely outlines enforcement mechanisms for noncompliance, including penalties, audits, and potential disciplinary actions by licensing boards or regulatory agencies.
-Effective dates and implementation
- Specifies when the new requirements take effect, and whether there are phased or staged implementations.
- May include transitional provisions for existing prescriptions or ongoing treatments.
Who would be affected
- Prescribers: physicians, nurse practitioners, physician assistants, dentists, and other authorized prescribers of controlled substances.
- Pharmacists and pharmacies delivering prescriptions for controlled drugs.
- Patients receiving prescriptions for controlled substances, including those on maintenance therapy or chronic pain management.
- Regulatory and licensing bodies overseeing controlled substances, prescription monitoring, and pharmacy practice.
- Health systems and clinics implementing PDMPs and updated prescribing workflows.
Significant procedural or timeline aspects
- Legislative history shows multiple stages of consideration, including:
- Introduction and referral to Health, Human Services and Elderly Affairs (January 2025).
- Public hearings and committee deliberations in early 2025.
- Committee amendments and “Ought to Pass with Amendment” recommendations in 2025.
- Floor actions culminating in a House concurring with Senate amendments in April 2026.
- The bill progressed through committee reports with amendments (notably Amendment #2025-3030s) and advanced through readings (Ought to Pass with Amendment, Third Reading, etc.).
- Final status: House concurred with Senate Amendment 2026-3030s in April 2026, indicating agreement on the amended version.
Notes and considerations
- The exact text of amendments (e.g., Amendment #2025-3030s) would specify precise changes to current law, including any new definitions, thresholds (dosage or quantity limits), or PDMP integration requirements.
- If you need, I can pull the bill’s specific statutory language to map each provision to current statute and identify potential fiscal impact, enforcement changes, and compliance steps for stakeholders.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
